Designing CD8+ T cell vaccines: it's not rocket science (yet).
CD8+ T cells play important roles in clearing viral infections and eradicating tumors. Designing vaccines that elicit effective CD8+ T cell responses requires a thorough knowledge of the pathways of antigen presentation in vivo. Here, I review recent progress in understanding the activation of naïve CD8+ T cells in vivo, with particular emphasis on cross-priming, the presentation of protein antigens acquired by dendritic cells from their environment. With the rapid advances in this area of research, the dawn of rational vaccine design is at hand.
Yewdell
Jonathan W
JW
Laboratory of Viral Diseases, NIAID, Bethesda, MD 20892, USA. JYEWDELL@nih.gov
D000818:Animals; D017951:Antigen Presentation / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D045142:Cross-Priming / Q000276:immunology; D015195:Drug Design; D006801:Humans; D008213:Lymphocyte Activation; D051379:Mice; D014612:Vaccines / Q000276:immunology*
D014612:Vaccines
J Biol Chem. 2005 Jun 10;280(23):21955-64
15781451
Biomacromolecules. 2009 Apr 13;10(4):756-65
19239276
J Immunol. 2003 Mar 1;170(5):2302-9
12594251
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6730-5
19346487
J Virol. 2009 Sep;83(18):9611-5
19553308
Int J Hyperthermia. 2008 Dec;24(8):623-37
18608582
Cytokine Growth Factor Rev. 2008 Feb;19(1):33-40
18068417
Immunity. 2008 Jun;28(6):787-98
18549799
Science. 2009 Jul 10;325(5937):213-7
19498108
J Exp Med. 1999 Feb 1;189(3):593-8
9927521
PLoS Pathog. 2009 May;5(5):e1000457
19478869
Clin Cancer Res. 2008 Jan 1;14(1):178-87
18172269
J Immunol. 2009 Jul 15;183(2):1083-90
19553546
J Immunol. 2002 Nov 1;169(9):5236-43
12391242
Nature. 2007 Nov 1;450(7166):110-4
17934446
Cancer Res. 2009 Aug 15;69(16):6607-14
19679552
J Immunol. 2007 Jun 1;178(11):7235-41
17513772
J Clin Invest. 2008 Jun;118(6):2098-110
18497879
Blood. 2007 Oct 15;110(8):2965-73
17562875
J Immunol. 2009 Jun 15;182(12):7587-94
19494282
J Immunol. 2006 Jun 1;176(11):6770-6
16709836
N Engl J Med. 2009 Nov 5;361(19):1838-47
19890126
Nat Immunol. 2003 Nov;4(11):1065-73
14566337
J Biol Chem. 2007 Oct 26;282(43):31688-702
17684010
J Immunol. 2005 Jul 15;175(2):796-805
16002676
Immunology. 2006 Jan;117(1):78-88
16423043
Immunity. 1995 Feb;2(2):137-47
7895170
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9202-7
16754858
Nat Immunol. 2008 May;9(5):551-7
18376401
J Immunol. 2007 Aug 15;179(4):2310-7
17675492
Eur J Immunol. 2010 Jan;40(1):103-12
19877013
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14984-9
19706459
Nat Immunol. 2006 Feb;7(2):165-72
16415871
J Exp Med. 2006 Mar 20;203(3):647-59
16505142
J Virol. 1998 Feb;72(2):1469-81
9445050
J Immunol. 2009 Nov 15;183(10):6145-50
19841190
J Exp Med. 2007 Sep 3;204(9):2187-98
17709425
Cell Host Microbe. 2009 Jan 22;5(1):13-21
19154984
Nat Rev Immunol. 2006 May;6(5):383-93
16622476
Immunology. 2006 Sep;119(1):63-73
16764686
Eur J Immunol. 2008 Apr;38(4):1033-42
18350546
Science. 2008 Nov 14;322(5904):1097-100
19008445
J Virol. 2008 Dec;82(23):11637-50
18815306
Virology. 2008 Jan 5;370(1):22-32
17904185
Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13426-31
17686978
J Immunol. 2007 Dec 15;179(12):8280-6
18056372
Apoptosis. 2009 Apr;14(4):364-75
19145485
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13980-5
16172378
PLoS Pathog. 2009 Oct;5(10):e1000618
19834548
Immunity. 2009 Apr 17;30(4):544-55
19328020
J Virol. 2006 Jul;80(13):6259-66
16775313
Science. 2007 Apr 27;316(5824):612-6
17463291
Eur J Immunol. 2004 Jan;34(1):194-9
14971045
Nature. 2003 Sep 25;425(6956):397-402
14508489
J Immunol. 2005 Jan 15;174(2):696-701
15634888
Expert Rev Vaccines. 2008 Sep;7(7):1019-30
18767951
Curr Opin Immunol. 2007 Feb;19(1):79-86
17140786
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3029-34
18272486
Nat Rev Immunol. 2003 May;3(5):427-32
12766764
Nature. 2009 Apr 16;458(7240):899-903
19219027
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3035-40
14978273
J Immunol. 2009 Mar 1;182(5):2654-64
19234159
Science. 2004 May 28;304(5675):1318-21
15166379
Nat Immunol. 2009 May;10(5):488-95
19349986
J Immunol. 2006 Nov 1;177(9):6018-24
17056526
Nat Immunol. 2008 Feb;9(2):155-65
18193049
Nat Immunol. 2009 Dec;10(12):1237-44
19915624
Blood. 2008 Oct 15;112(8):3264-73
18669894
Nat Immunol. 2007 Jan;8(1):101-8
17128277
Eur J Immunol. 2009 Feb;39(2):380-90
19130478
J Virol. 2007 Nov;81(21):11925-36
17699574
Mol Immunol. 2008 Nov;46(1):181-91
18804283
Biol Chem. 2008 May;389(5):521-36
18953718
Biomaterials. 2009 Mar;30(7):1356-62
19091401
J Biol Chem. 2007 Feb 16;282(7):4479-4484
17178717
Nat Immunol. 2003 Sep;4(9):815
12942076
J Exp Med. 2005 Sep 19;202(6):817-28
16157687
J Virol. 2008 May;82(9):4331-42
18305030
Annu Rev Immunol. 2005;23:651-82
15771583
Science. 2004 May 28;304(5675):1314-7
15166378
Eur J Immunol. 2007 Jun;37(6):1453-62
17474148
Nature. 2005 Mar 3;434(7029):83-8
15744304
Eur J Immunol. 2009 Apr;39(4):931-8
19197943
Nat Immunol. 2008 May;9(5):558-66
18376402
J Exp Med. 2008 Jul 7;205(7):1621-34
18591406
Immunology. 1999 Jun;97(2):316-24
10447748
Eur J Immunol. 2002 Sep;32(9):2385-92
12207322
J Immunol. 2003 Oct 1;171(7):3718-24
14500671
J Leukoc Biol. 2008 Oct;84(4):988-93
18515327
Immunity. 2006 May;24(5):523-34
16713971
J Immunol. 2007 Aug 15;179(4):2126-33
17675471
J Immunol. 2009 Mar 15;182(6):3650-9
19265143
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3485-90
10725409
J Immunol. 2008 Feb 1;180(3):1482-9
18209043
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13790-5
11095746
Clin Vaccine Immunol. 2008 Oct;15(10):1497-504
18753338
Vaccine. 2008 Mar 20;26(13):1626-37
18295941
J Exp Med. 2000 Jun 5;191(11):1957-64
10839810
Eur J Immunol. 2007 Aug;37(8):2063-74
17628858